Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responses
适合记住吗?
基本信息
- 批准号:8888712
- 负责人:
- 金额:$ 19.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAddressAdoptive TransferAffinityAllelesAnabolismAntibodiesAntibody FormationAntibody ResponseAntidiabetic DrugsAntigensAutoimmune DiseasesAutoimmunityB-LymphocytesBiochemicalBiological ModelsBiologyCD8B1 geneCell LineageCell SurvivalCell physiologyCellsCharacteristicsClinical DataComplementComplexDataDiseaseEpitopesEquilibriumFosteringGenerationsGlucoseGlycolysisHealthHumoral ImmunitiesHypoxiaImmuneImmune responseImmune systemImmunityImmunoglobulin GImmunoglobulin MIn VitroInterleukin-4LeadLearningLeukocytesLifeLipidsLymphoidMaintenanceMeasuresMediatingMemoryMemory B-LymphocyteMetabolicMetabolic PathwayMetabolismMetforminMicrobeModelingMusNatureNutrientOutcomePathway interactionsPerformancePhenotypePhosphotransferasesPhysiologyPlasma CellsPopulationProcessProtein IsoformsProteinsReactionRegulationResearchRoleSTAT6 geneSignal PathwaySignal TransductionStagingStructure of germinal center of lymph nodeSystems DevelopmentT-LymphocyteTestingTransferaseTransgenesVaccinesWorkadaptive immunityanaerobic glycolysisbaseclinical practiceeffective therapyfatty acid oxidationfitnessfunctional outcomesgain of functionimprovedlong term memoryloss of functionmTOR proteinmouse modelnoveloxidationpublic health relevanceresponsesensortranscription factorvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): Humoral memory, a key feature of both adaptive immunity and some autoimmune diseases, is central to the capacity of vaccines to protect against microbes. Determinants of this process include the degrees to which germinal center (GC) and extrafollicular reactions foster the differentiation and maintenance of various classes of memory B (Bmem) cells from which recall responses are derived. Much has been learned about the potential fates of a B cell after its activation, including vital contributions of BCR affinity for Ag, but remarkably little is known about how signaling within the B cell impacts memory or recall. Accumulating evidence with in vitro manipulations as well as mouse model systems provides indications of a regulatory interplay of local physiology (e.g., nutrient supply) with signaling in cells of the immune system and their fate or functional characteristics. The unique biology of B cells suggests that they use novel mechanisms, but very little is known about metabolic regulation for the B lymphoid lineage and especially not for the persistence of classes of Bmem cells or adequate concentrations of Ab. AMP-activated kinase (AMPK), a target of anti-diabetic agents such as metformin, is central to regulation of the balance between energy generation versus utilization in bio-synthesis. We have found that the predominant isoform of AMPK in B cells, AMPKa1, promoted the capacity for a recall Ab response in a B cell- intrinsic role. We also developed evidence of a pathway parallel to AMPK, on which an ADP-ribosyl transferase, PARP14, promotes increases in glycolysis, glucose oxidation, and B cell survival. Moreover recall Ab responses of several Ab isotypes depended on PARP14. These and further findings lead us to hypothesize that AMPKa promotes the generation or maintenance of Ag-specific IgG+ memory B cells, and that this function is exerted at least in part through promotion of metabolic fitness [fatty acid oxidation (FAO), glycolysis, and glucose oxidation]. The research also will address an unresolved paradox from key studies of the central paradigm of CTL memory, in which (FAO) is associated with memory fate while glycolysis ties to effector-like phenotype. The conundrum is that the balancing act was attributed to AMPK activity, but this kinase promotes both FAO and glycolysis. We will test the hypothesis that differential regulation of these forms of energy generation is based on activity of hypoxia- induced factor(s) (HIFs - 1, 2), transcription factors that may directly repress FAO alongside its activation of glycolysis. To test the impact of AMPK activity on humoral recall, and elucidate a mechanism by which metabolic pathways can be balanced, we have three specific Aims. The first (Aim 1) is to establish a specific B lineage- intrinsic function for the key metabolic regulaor, AMPK, in memory and identify stages at which it is required. In Aim 2, we will test a model in which HIFs are integrated with AMPK in setting B cell metabolic balance and recall Ab responses. Finally, we will evaluate if mTOR is an effector of AMPK in B cells and humoral memory (Aim 3). The expected outcome of the proposed studies is that we will uncover novel roles for AMPK and HIF- 1 in determining the metabolic profile in B cells and functional outcomes in humoral immunity.
描述(由申请人提供):体液记忆是适应性免疫和一些自身免疫性疾病的关键特征,对于疫苗预防微生物的能力至关重要。这一过程的决定因素包括生发中心 (GC) 和滤泡外反应促进各类记忆 B (Bmem) 细胞分化和维持的程度,而回忆反应正是从这些细胞中产生的。人们对 B 细胞激活后的潜在命运了解很多,包括 BCR 对 Ag 亲和力的重要贡献,但对 B 细胞内的信号传导如何影响记忆或回忆却知之甚少。通过体外操作和小鼠模型系统积累的证据提供了局部生理学(例如营养供应)与免疫系统细胞信号传导及其命运或功能特征之间的调节相互作用的迹象。 B 细胞独特的生物学特性表明它们使用新的机制,但人们对 B 淋巴谱系的代谢调节知之甚少,尤其是对 Bmem 细胞类别的持续存在或足够浓度的 Ab 的了解甚少。 AMP 激活激酶 (AMPK) 是二甲双胍等抗糖尿病药物的靶标,对于调节生物合成中能量产生与利用之间的平衡至关重要。我们发现 B 细胞中 AMPK 的主要亚型 AMPKa1 促进了 B 细胞内在作用中回忆 Ab 反应的能力。我们还发现了与 AMPK 平行的途径的证据,在该途径上,ADP-核糖基转移酶 PARP14 促进糖酵解、葡萄糖氧化和 B 细胞存活的增加。此外,几种抗体同种型的抗体反应依赖于 PARP14。这些和进一步的发现使我们推测 AMPKa 促进 Ag 特异性 IgG+ 记忆 B 细胞的生成或维持,并且这种功能至少部分是通过促进代谢适应性 [脂肪酸氧化 (FAO)、糖酵解和葡萄糖氧化] 来发挥的。该研究还将解决 CTL 记忆中心范式关键研究中尚未解决的悖论,其中 (FAO) 与记忆命运相关,而糖酵解与效应器样表型相关。难题在于平衡作用归因于 AMPK 活性,但这种激酶同时促进FAO和糖酵解。我们将检验以下假设:这些形式的能量产生的差异调节是基于缺氧诱导因子 (HIF - 1, 2) 的活性,这些转录因子可能会在糖酵解激活的同时直接抑制FAO。为了测试 AMPK 活性对体液回忆的影响,并阐明平衡代谢途径的机制,我们有三个具体目标。第一个目标(目标 1)是为记忆中的关键代谢调节因子 AMPK 建立特定的 B 谱系内在功能,并确定需要它的阶段。在目标 2 中,我们将测试一个模型,其中 HIF 与 AMPK 整合以设置 B 细胞代谢平衡并回忆 Ab 反应。最后,我们将评估 mTOR 是否是 B 细胞和体液记忆中 AMPK 的效应子(目标 3)。拟议研究的预期结果是,我们将发现 AMPK 和 HIF-1 在确定 B 细胞代谢特征和体液免疫功能结果方面的新作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark R Boothby其他文献
Mark R Boothby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark R Boothby', 18)}}的其他基金
Antibody quality and germinal center requirements for peroxisomal function in lymphocytes
淋巴细胞过氧化物酶体功能的抗体质量和生发中心要求
- 批准号:
10469589 - 财政年份:2021
- 资助金额:
$ 19.63万 - 项目类别:
Antibody quality and germinal center requirements for peroxisomal function in lymphocytes
淋巴细胞过氧化物酶体功能的抗体质量和生发中心要求
- 批准号:
10318012 - 财政年份:2021
- 资助金额:
$ 19.63万 - 项目类别:
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
TNBC肿瘤细胞谷氨酰胺代谢对抗肿瘤免疫的影响
- 批准号:
10430078 - 财政年份:2020
- 资助金额:
$ 19.63万 - 项目类别:
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
TNBC肿瘤细胞谷氨酰胺代谢对抗肿瘤免疫的影响
- 批准号:
10219207 - 财政年份:2020
- 资助金额:
$ 19.63万 - 项目类别:
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
TNBC肿瘤细胞谷氨酰胺代谢对抗肿瘤免疫的影响
- 批准号:
10656440 - 财政年份:2020
- 资助金额:
$ 19.63万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
10529278 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
10062829 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
9889587 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
10306395 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responses
适合记住吗?
- 批准号:
9204785 - 财政年份:2015
- 资助金额:
$ 19.63万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 19.63万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 19.63万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 19.63万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 19.63万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 19.63万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 19.63万 - 项目类别:
Studentship Programs














{{item.name}}会员




